Regulation of the Rho GEF Pebble in Fibroblast Growth Factor dependent cell migration
Regulation of the Rho GEF Pebble in Fibroblast Growth Factor dependent cell migration
批准号:
MR/K018531/1
负责人:
Arno Muller
金额:
$51.09万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
细胞移动的能力在人体内是一个高度调控的过程。细胞可以发送和接收信号,使它们能够以受控的方式改变在生物体中的位置。这些信号作用于细胞内一种叫做细胞骨架的机器,它允许细胞在有机体或基质上向前推进。细胞迁移调节的缺陷是许多严重的人类疾病和过多的先天性疾病的原因。因此,研究信号的分子细节及其在细胞迁移中的作用对于我们了解人类疾病并开发针对它们的治疗方法至关重要。由于显而易见的原因,我们无法对人类进行实验,因此对人类细胞疾病途径的研究常常受到阻碍。一种可能性是利用患病细胞或组织,但这些细胞或组织不再与整个生物体接触,因此只能提供有限的见解。另一种可能性是使用所谓的模式生物。由于所有多细胞动物的主要遗传库惊人地相似,我们可以使用简单的生物体来研究人类的疾病途径。我们的实验室正在使用果蝇黑腹果蝇,它在生物医学研究中已经使用了100多年。果蝇的力量在于它很容易通过突变和其他修改来操纵它的基因。我们之前的研究已经确定了一种由成纤维细胞生长因子触发的信号通路,该信号通路负责苍蝇胚胎中细胞迁移的开始和方向性。由于非常相似的分子在人类胚胎中发挥相似的功能,我们的研究结果可转移到人类身上。为了确定通过成纤维细胞生长因子信号调节细胞迁移的分子,我们进行了大规模的基因实验。这些基因筛选发现了其他基因的突变,然后我们证明了这些突变对细胞迁移过程中细胞骨架的调节很重要。在这个研究项目中,我们计划确定这种调节是如何在分子水平上发生的,以及生长因子如何改变细胞骨架重要调节因子的活性和定位。我们期望这项研究的结果将为药物发现项目的研究提供新的机会,以建立可以检测小化合物的检测方法,从而导致细胞迁移异常的疾病的新治疗方法。
英文摘要
The capability of cells to move is a highly regulated process in the human body. Cells can send and received signals that enable them to change position in an organism in a controlled fashion. These signals act upon a machine within the cell called the cytoskeleton, which allows cells to propel themselves forward in an organism or upon a substrate. Defects in the regulation of cell migration are the cause of many severe human diseases and a plethora of congenital disorders. Therefore to investigate the molecular detail of the signals and their action in cell migration is of utmost importance for our understanding of human diseases and to develop treatments against them.Research on human cellular disease pathways is often hampered by the fact that we cannot do experiments with humans for obvious reasons. One possibility is to utilise diseased cells or tissues, but these are no longer in contact with the entire organism and thus only provided limited insight. Another possibility is the use of so called model organisms. As the principal genetic repertoire of all multicellular animals is surprisingly similar, we can use simple organisms to investigate human disease pathways. Our laboratory is using the fruit fly Drosophila melanogaster, which has been employed for over 100 year in biomedical research. The power of Drosophila lies in its ease to manipulate its genes by mutations and other modifications. Our previous research has identified a signalling pathway triggered by a Fibroblast Growth Factor that is responsible for the onset and the directionality of cell migration in the fly embryo. As very similar molecules exerts similar functions in human embryos, our research results are transferable to humans.To identify the molecules that are involved in the regulation of cell migration through Fibroblast Growth Factor signalling we have conducted large scale genetic experiments. These genetic screens found mutations in other genes, which we then showed to be important for the regulation of the cytoskeleton during cell migration. In this research project we plan to determine how this regulation occurs on the molecular level and how the growth factor can modify the activity and the localisation of an important regulator of the cytoskeleton. We expect that the results from this research will provide new opportunities for research in drug discovery projects to establish assays that can detect small compounds leading to novel treatments of diseases in which cell migration is abnormal.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1242/dev.104711
发表时间:
2014-05
期刊:
Development (Cambridge, England)
影响因子:
--
作者:
[Hain D, Langlands A, Sonnenberg HC, Bailey C, Bullock SL, Müller HA]
通讯作者:
Müller HA
DOI:
10.1098/rsob.150234
发表时间:
2015-12
期刊:
Open biology
影响因子:
5.8
作者:
[Mariappa D, Zheng X, Schimpl M, Raimi O, Ferenbach AT, Müller HA, van Aalten DM]
通讯作者:
van Aalten DM
Role of Fibroblast-Growth Factor Signalling in Epithelial Remodelling
-
批准号:G0901020/1
-
项目类别:Research Grant
-
资助金额:$41.51万
-
财政年份:2010
-
负责人:Arno Muller
-
依托单位:
Analysis of FGF-signalling mechanisms in controlling cell migration in Drosophila
-
批准号:G0501679/1
-
项目类别:Fellowship
-
资助金额:$209.75万
-
财政年份:2006
-
负责人:Arno Muller
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Rho-GTPase 通过调控TNTs 组装保障TC-cTECs间线粒体转移促进产后胸腺再生的机制研究
-
批准号:ZCLQN26H0401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:许勰
-
依托单位:
Rho/ROCK2调节周细胞收缩参与慢性脑缺血引起的血管性认知障碍的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘巧艳
-
依托单位:
CHRNA9介导Rho/ROCK信号通路促进非小细胞肺癌侵袭、迁移及顺铂耐药的研究
-
批准号:2025JJ80889
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:梁露
-
依托单位:
Rho激酶抑制剂Y-27632对急性高眼压致角膜内皮损伤的保护及促修复作用研究
-
批准号:JCZRLH202500765
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
大黄灵仙方调控Rho-Wnt交互通路影响骨架重塑—凋亡抑制胆管炎症的细胞力学机制研究
-
批准号:82560936
-
项目类别:地区科学基金项目
-
资助金额:33.00万元
-
批准年份:2025
-
负责人:张曼
-
依托单位:
PPARγ/RAD21通过上调GAP43表达并抑制Rho/ROCK活性从而增强隧道纳米管(TNTs)介导的线粒体转移促进脑出血后神经保护及损伤修复的分子机制
-
批准号:82560244
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:伍国锋
-
依托单位:
海胆病原菌致病毒力因子通过Rho-GTPase家族影响宿主免疫应答的分子机制研究
-
批准号:32573534
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:湛垚垚
-
依托单位:
法舒地尔通过CaMK4/Rho GTPases信号修复足细胞肌动蛋白骨架治疗狼疮性肾炎的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:田丰源
-
依托单位:
细胞外整合素配体分布和细胞内Rho GTP
酶活性协同调控肿瘤细胞迁移的力学生
物学机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:胡训武
-
依托单位:
单细胞和空间转录组揭示近端小管上皮细胞内TMPO通过Rho GTP酶通路促进BK多瘤病毒肾病进展的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:黄刚
-
依托单位: